Last reviewed · How we verify
Rhinoscleroma
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Cefaprin · Bristol-Myers Squibb
- Amoxycillin · King George's Medical University
- Avelox · Bayer AG
Fourth-generation fluoroquinolone with the broadest spectrum, covering gram-positive, gram-negative, anaerobic, and atypical organisms. - Tobi · Novartis
- Unasyn · Bristol-Myers Squibb
- Unasyn · Pfizer
- Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - Amoxil · Generic (originally Beecham/GSK)
Broad-spectrum aminopenicillin that inhibits bacterial cell wall synthesis by binding penicillin-binding proteins. - Ciprofloxacine · Poitiers University Hospital
- Vantobra · Pfizer
- Gentamicin · Merck & Co.
- Nebcin · University Hospital, Lille
- Avelox · Novartis Pharmaceuticals
- Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Azactam · Bristol-Myers Squibb
Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent. - Arikayce Kit · Bristol-Myers Squibb
Amikacin works by binding to bacterial ribosomes, inhibiting protein synthesis and ultimately killing the bacteria. - Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Mefoxin In Sodium Chloride 0.9% In Plastic Container
- Teflaro · AbbVie
Teflaro works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - TICARCILLIN
- Ticarcillin
- Zinacef · GSK
Zinacef works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Augmentin 250 · Dr Reddys Labs Inc
- Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Noroxin
- Floxin
- Epocelin
- Cipro · Bayer AG
- Rocephin · Generic (originally Roche)
- Ceftazidim · Tel-Aviv Sourasky Medical Center
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
- Amoxicilli · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Rhinoscleroma patent landscape — cliff calendar, originator estates, attackable patents
- Rhinoscleroma treatment landscape brief
- Rhinoscleroma treatment updates RSS
Frequently asked questions about Rhinoscleroma
What drugs treat Rhinoscleroma?
Tracked treatments include Ramycin, Garamycin, Cefaprin, Amoxycillin, Avelox, Tobi, Unasyn, Pipracil.
What is the treatment for Rhinoscleroma?
Standard treatment for Rhinoscleroma includes Ramycin, Garamycin, Cefaprin, Amoxycillin, Avelox. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Rhinoscleroma patent cliff · Rhinoscleroma CI report
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Cefaprin · Bristol-Myers Squibb
- Treatment: Amoxycillin · King George's Medical University
- Treatment: Avelox · Bayer AG
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing